PharmaShots | Incisive News in 3 Shots

Subscribe Now

Efgartigimod

Argenx Reports EMA's Validation of MAA for Efgartigimod to Treat Generalized Myasthenia Gravis

Argenx Reports EMA's Validation of MAA for Efgartigimod to Treat Generalized Myasthenia Gravis

August 25, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us